TABLE I.
Baseline demographic and clinical characteristics of the liver transplant recipients
| Characteristic | Value |
|---|---|
| Patients (n) | 35 |
| Sex [n (%)] | |
| Men | 31 (88.6) |
| Women | 4 (11.4) |
| Mean age (years) | 61.7±7.2 |
| Follow-up (months) | |
| Mean | 27±22 |
| Range | 1–72 |
| Mean bmi (kg/m2) | 26.5±4.4 |
| Cirrhosis [n (%)] | |
| Present | 32 (91.4) |
| Cause | |
| Hepatitis C virus | 15 (42.9) |
| Hepatitis B virus | 8 (22.9) |
| nash | 8 (22.9) |
| aat deficiency | 1 (2.9) |
| Autoimmune hepatitis | 1 (2.9) |
| Hemochromatosis | 1 (2.9) |
| Mean meld score | 21.1±1.8 |
| Serum αfp (ng/mL) | |
| Median | 43 |
| Range | 8.55–118.25 |
bmi = body mass index; aat deficiency = α1-antitrypsin deficiency; nash = nonalcoholic steatohepatitis; meld = model for end-stage liver disease; αfp = alpha-fetoprotein.